Assessment of Labrasol/Labrafil/Transcutol (4/4/2, v/v/v) as a non-clinical vehicle for poorly water-soluble compounds after 4-week oral toxicity study in Wistar rats.

MLA

Delongeas, J. L., et al. “Assessment of Labrasol/Labrafil/Transcutol (4/4/2, v/v/v) as a Non-Clinical Vehicle for Poorly Water-Soluble Compounds after 4-Week Oral Toxicity Study in Wistar Rats.” Regulatory Toxicology and Pharmacology : RTP, vol. 57, no. 2–3, July 2010, pp. 284–90. EBSCOhost, https://doi.org/10.1016/j.yrtph.2010.03.008.

APA

Delongeas, J.-L., de Conchard, G. V., Beamonte, A., Bertheux, H., Spire, C., Maisonneuve, C., Becourt-Lhote, N., Goldfain-Blanc, F., & Claude, N. (2010). Assessment of Labrasol/Labrafil/Transcutol (4/4/2, v/v/v) as a non-clinical vehicle for poorly water-soluble compounds after 4-week oral toxicity study in Wistar rats. Regulatory Toxicology and Pharmacology : RTP, 57(2–3), 284–290. https://doi.org/10.1016/j.yrtph.2010.03.008

Chicago

Delongeas, J-L, G Vermeil de Conchard, A Beamonte, H Bertheux, C Spire, C Maisonneuve, N Becourt-Lhote, F Goldfain-Blanc, and N Claude. 2010. “Assessment of Labrasol/Labrafil/Transcutol (4/4/2, v/v/v) as a Non-Clinical Vehicle for Poorly Water-Soluble Compounds after 4-Week Oral Toxicity Study in Wistar Rats.” Regulatory Toxicology and Pharmacology : RTP 57 (2–3): 284–90. doi:10.1016/j.yrtph.2010.03.008.